The proceedings of brain metastases from lung cancer
Abstract: Brain tumors include primary tumors of various intracranial tissue and secondary intracranial tumors that transferred from other parts of the body. Secondary intracranial tumors are especially prevalent in patients with lung cancer. The mechanisms of lung cancer with brain metastases are complicated, they are affected by a variety of factors. Thus, identifying the mechanisms of lung cancer with brain metastases will have far-reaching meanings both for clinic pharmacy research and for a better quality of life for patients; Brain metastases from lung cancer represent a prevalent and challenging clinical dilemma, and some research suggests that the outcomes and characteristics of brain metastases that result from lung cancer primary sites are perhaps different than those from other primary sites, therefore increasing the difficulty of clinical treatment. Despite steady research developments during recent years, the survival rates remain poor. The mechanisms and therapeutic options for treating brain metastases arising from lung cancer are review in this article.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
The proceedings of brain metastases from lung cancer ; volume:11 ; number:1 ; year:2016 ; pages:116-121 ; extent:6
Open life sciences ; 11, Heft 1 (2016), 116-121 (gesamt 6)
- Creator
-
Zhao, Hang
Li, Guijie
Yu, Chunlei
An, Zhe
- DOI
-
10.1515/biol-2016-0016
- URN
-
urn:nbn:de:101:1-2409201633178.565315234495
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhao, Hang
- Li, Guijie
- Yu, Chunlei
- An, Zhe
Other Objects (12)
Contraction of T cell richness in lung cancer brain metastases
Duodenal Metastases from Lung Cancer
TopBP1 and Claspin contribute to the radioresistance of lung cancer brain metastases
Effect of whole-brain radiotherapy with platinum-based chemotherapy in non-small cell lung cancer patients with multiple metastases including brain metastases
Metastases to breast from primary lung cancer
Cognitive changes are associated with increased blood-brain barrier leakage in non-brain metastases lung cancer patients
Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung Cancer
Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
Prognostic factors of brain metastases from colorectal cancer
Prognostic scores in brain metastases from breast cancer
Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity
Development and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases
Contraction of T cell richness in lung cancer brain metastases
Duodenal Metastases from Lung Cancer
TopBP1 and Claspin contribute to the radioresistance of lung cancer brain metastases
Effect of whole-brain radiotherapy with platinum-based chemotherapy in non-small cell lung cancer patients with multiple metastases including brain metastases
Metastases to breast from primary lung cancer
Cognitive changes are associated with increased blood-brain barrier leakage in non-brain metastases lung cancer patients
Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung Cancer
Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
Prognostic factors of brain metastases from colorectal cancer
Prognostic scores in brain metastases from breast cancer
Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity
Development and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases
Contraction of T cell richness in lung cancer brain metastases
Duodenal Metastases from Lung Cancer
TopBP1 and Claspin contribute to the radioresistance of lung cancer brain metastases
Effect of whole-brain radiotherapy with platinum-based chemotherapy in non-small cell lung cancer patients with multiple metastases including brain metastases
Metastases to breast from primary lung cancer
Cognitive changes are associated with increased blood-brain barrier leakage in non-brain metastases lung cancer patients
Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung Cancer
Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
Prognostic factors of brain metastases from colorectal cancer
Prognostic scores in brain metastases from breast cancer
Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity